ZNF490 Inhibitors
Chemical inhibitors of ZNF490 can act through various mechanisms to inhibit its function by targeting different cellular processes and signaling pathways. Palbociclib and PD0332991, both CDK4/6 inhibitors, can prevent the phosphorylation of proteins that are necessary for the proper function of ZNF490 as a transcription factor. Since CDK-mediated phosphorylation is often crucial for the activation and stabilization of transcription factors, the activity of ZNF490 can be effectively inhibited by these drugs. Similarly, the selective inhibition of Aurora A kinase by MLN8237 and the broader inhibition of Aurora kinases by VX-680 can disrupt cell cycle events and mitotic spindle formation that ZNF490 is likely involved in, thereby inhibiting its function within these processes.
Y-27632, a ROCK inhibitor, affects cytoskeletal dynamics, which can, in turn, influence the transcriptional activity regulated by ZNF490 by altering cell shape or tension. SP600125, which inhibits JNK, can obstruct signaling pathways associated with stress responses that ZNF490 may be a part of, leading to its inhibition. The PI3K/Akt pathway, targeted by LY294002, is another signaling route that can be integral to ZNF490's role in transcriptional regulation. Furthermore, Rapamycin's inhibition of the mTOR pathway can disrupt cell growth and metabolic processes that are potentially governed by ZNF490-regulated gene expression. Inhibition by PD98059 and U0126 of the MEK inhibitors prevents the activation of the ERK/MAPK pathway, which is essential for the transcriptional regulation activities of ZNF490. SB203580's inhibition of the p38 MAPK can interrupt cellular responses to stress and inflammation regulated by ZNF490. Lastly, Gefitinib's inhibition of the EGFR kinase activity can block upstream signaling that regulates ZNF490, thereby inhibiting its functional activity within these pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib is a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. ZNF490 is a transcription factor that may require CDK-mediated phosphorylation for proper function. By inhibiting CDK4/6, Palbociclib can prevent the phosphorylation of proteins essential for ZNF490's role in transcriptional regulation, leading to functional inhibition. | ||||||
MLN8237 | 1028486-01-2 | sc-394162 | 5 mg | $220.00 | ||
MLN8237 selectively inhibits Aurora A kinase, which is involved in the regulation of mitosis. As ZNF490 is implicated in cell cycle regulation, the inhibition of Aurora A kinase can disrupt the cell cycle events that ZNF490 is involved in, thereby inhibiting its function. | ||||||
Tozasertib | 639089-54-6 | sc-358750 sc-358750A | 25 mg 50 mg | $62.00 $87.00 | 4 | |
VX-680, also known as MK-0457, is an inhibitor of Aurora kinases. By blocking the activity of these kinases, VX-680 can interfere with cell cycle progression and mitotic spindle formation, processes that ZNF490 may regulate or be influenced by, resulting in its functional inhibition. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor that affects cytoskeletal organization. ZNF490's transcriptional activity could be modulated by alterations in cell shape or tension, and the inhibition of ROCK can lead to changes in these cellular properties, thus inhibiting ZNF490's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of the c-Jun N-terminal kinase (JNK). JNK is part of stress response pathways, and by inhibiting JNK, SP600125 can interrupt signaling that ZNF490 may be involved in, leading to its functional inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which could lead to the inhibition of the PI3K/Akt pathway. ZNF490 may rely on this pathway for some aspects of its function in transcriptional regulation, and disruption of this pathway by LY294002 can inhibit ZNF490's activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, a key regulator of cell growth and metabolism. Since ZNF490 is a transcription factor that could be influencing gene expression related to these processes, inhibition of mTOR by Rapamycin can lead to the functional inhibition of ZNF490. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that prevents the activation of ERK/MAPK pathway. This pathway may be essential for ZNF490's role in transcriptional regulation, and its inhibition by PD98059 can result in the functional inhibition of ZNF490. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor which could disrupt the cellular response to stress and inflammatory signals that ZNF490 may regulate, leading to the functional inhibition of ZNF490. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor that blocks MAPK/ERK pathway activation. By inhibiting this pathway, U0126 can interfere with the signaling required for ZNF490's transcriptional activity, resulting in functional inhibition. | ||||||